13.1K(top 3%)
articles
344.1K(top 3%)
citations
2,452(top 3%)
★★ articles
132(top 2%)
★★★ articles
3.1(top 12%)
Avg IF
190(top 3%)
H-Index
336(top 3%)
G-Index
2,677
journals

Most Cited Articles of Sydney Medical School in 2017

TitleJournalYearCitations
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine20172.7K
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease StudyJAMA Oncology20172.4K
Parkinson diseaseNature Reviews Disease Primers20171.7K
Chronic Kidney DiseaseLancet, The20171.3K
Non-specific low back painLancet, The2017849
Whole-genome landscapes of major melanoma subtypesNature2017662
The Human Phenotype Ontology in 2017Nucleic Acids Research2017507
Selective neuronal vulnerability in Parkinson diseaseNature Reviews Neuroscience2017465
Exercise to prevent falls in older adults: an updated systematic review and meta-analysisBritish Journal of Sports Medicine2017436
Evidence for overuse of medical services around the worldLancet, The2017399
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyMovement Disorders2017375
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialLancet, The2017336
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyLancet Oncology, The2017330
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialLancet Diabetes and Endocrinology,the2017330
Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteriaBiochemical Pharmacology2017296
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment OptionsNeuroscience Bulletin2017292
Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysisMolecular Psychiatry2017284
A three-talk model for shared decision making: multistage consultation processBMJ, The2017275
Engineering a sprayable and elastic hydrogel adhesive with antimicrobial properties for wound healingBiomaterials2017273
Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-makingThrombosis and Haemostasis2017265
Neanderthal behaviour, diet, and disease inferred from ancient DNA in dental calculusNature2017263
Cognitive Function in a Randomized Trial of EvolocumabNew England Journal of Medicine2017263
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer riskNature Genetics2017257
Dilated cardiomyopathyLancet, The2017244
Virus genomes reveal factors that spread and sustained the Ebola epidemicNature2017238